Intraindividual Blood Pressure Responses to Angiotensin‐Converting Enzyme Inhibition and Angiotensin Receptor Blockade

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Blood Pressure Responses ◽

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Journal of the American Society of Nephrology ◽

10.1681/asn.2009070737 ◽

2009 ◽

Vol 20 (12) ◽

pp. 2641-2650 ◽

Cited By ~ 233

Author(s):

Uzma F. Mehdi ◽

Beverley Adams-Huet ◽

Philip Raskin ◽

Gloria L. Vega ◽

Robert D. Toto

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade

Atlas of Heart Failure ◽

10.1007/978-1-4615-6490-4_11 ◽

2002 ◽

pp. 193-209

Author(s):

Todd M. Koelling ◽

Robert J. Cody

Keyword(s):

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Effects of Angiotensin Converting Enzyme Inhibition or Angiotensin Receptor Blockade in Dialysis Patients

Medicine ◽

10.1097/md.0000000000000424 ◽

2015 ◽

Vol 94 (3) ◽

pp. e424 ◽

Cited By ~ 11

Author(s):

Cho-Kai Wu ◽

Yao-Hsu Yang ◽

Jyh-Ming Jimmy Juang ◽

Yi-Chih Wang ◽

Chia-Ti Tsai ◽

...

Keyword(s):

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Dialysis Patients ◽

Comparative Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin-Receptor Blockade on Inflammation during Hemodialysis

Journal of the American Society of Nephrology ◽

10.1681/asn.2011030287 ◽

2011 ◽

Vol 23 (2) ◽

pp. 334-342 ◽

Cited By ~ 29

Author(s):

Jorge L. Gamboa ◽

Mias Pretorius ◽

Deanna R. Todd-Tzanetos ◽

James M. Luther ◽

Chang Yu ◽

...

Keyword(s):

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy

Yearbook of Medicine ◽

10.1016/s0084-3873(10)79697-8 ◽

2010 ◽

Vol 2010 ◽

pp. 206-208

Author(s):

R. Garrick

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

The Impact of Angiotensin Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade on Tissue Expression of the SARS‐CoV‐2 Receptor ACE2 in Mice

The FASEB Journal ◽

10.1096/fasebj.2021.35.s1.04584 ◽

2021 ◽

Vol 35 (S1) ◽

Author(s):

Aline Silva Moreira ◽

Steven Brooks ◽

Rachel Smith ◽

Ian Moore ◽

Hans Ackerman

Keyword(s):

Enzyme Inhibition ◽

Tissue Expression ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Angiotensin Receptor Blockade ◽

The Impact

Angiotensin-converting enzyme inhibition or angiotensin receptor blockade in hypertensive diabetics?

Current Hypertension Reports ◽

10.1007/s11906-003-0080-3 ◽

2003 ◽

Vol 5 (5) ◽

pp. 364-367 ◽

Cited By ~ 2

Author(s):

Gozewÿn Laverman ◽

Piero Ruggenenti ◽

Giuseppe Remuzzi

Keyword(s):

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Progress in Experimental Cardiology - Angiotensin II Receptor Blockade Physiological and Clinical Implications ◽

At1 Angiotensin Receptor Blockade and Angiotensin Converting Enzyme Inhibition: Effects on Vascular Remodeling and Endothelial Dysfunction in Shr

10.1007/978-1-4615-5743-2_3 ◽

1998 ◽

pp. 33-40 ◽

Cited By ~ 1

Author(s):

Ernesto L. Schiffrin ◽

Jin-S. Li ◽

Ali M. Sharifi

Keyword(s):

Endothelial Dysfunction ◽

Enzyme Inhibition ◽

Vascular Remodeling ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Faculty Opinions recommendation of Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1448963.926064 ◽

2010 ◽

Author(s):

Mai Ots-Rosenberg

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Faculty of 1000 evaluation for Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.1448963.2221054 ◽

2010 ◽

Author(s):

Luigi Gnudi

Keyword(s):

Diabetic Nephropathy ◽

Enzyme Inhibition ◽

Receptor Blockade ◽

Converting Enzyme ◽

Angiotensin Receptor ◽